A study across all molecular subtypes of CRC has demonstrated that a gene program induced by TGF-β in tumor stromal cells can predict poor prognosis across all subtypes (44), leading to the question of whether TGF-β and TGF-β–induced collagens could play a role in CRC resistance to ICB. Here, TGFB1 is linked to neoplasm.